InMed Pharmaceuticals Inc (INM)

1.32 -0.02 (-1.49%) USD  |  NASDAQ  |  Jun 01, 16:00
1.31 -0.01 (-0.76%) After-Hours: 20:00
More

InMed Pharmaceuticals News

News

Headline
Wire
Time (ET)
InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting
Yahoo
06/01 07:30
InMed to Participate in Upcoming Virtual Investor Events
Yahoo
05/24 18:51
Lucy Scientific, Bioventus top healthcare gainers; Enveric, Elevation among losers
SA Breaking News
05/19 10:04
InMed to Participate in Fireside Chat with Water Tower Research on May 23, 2023 at 1pm ET
Yahoo
05/18 17:00
InMed Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
Yahoo
05/15 12:33
InMed Pharmaceuticals Completes Patient Enrollment for Phase 2 Trial of INM-755 in Epidermolysis Bullosa
MT Newswires
03/28 12:12
InMed Announces Conclusion of Patient Enrollment in Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
Yahoo
03/28 07:30
THMO and RSLS among healthcare movers
SA Breaking News
03/20 10:29
Top Premarket Gainers
MT Newswires
03/20 07:47
InMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions
Yahoo
03/13 07:30
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Globe Newswire
03/10 08:35
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
Globe Newswire
03/07 08:35
Presenting on the Emerging Growth Conference on March 8 Register Now
Globe Newswire
03/07 07:00
InMed to Participate in Upcoming Investor Events
Yahoo
03/06 18:00
InMed Pharmaceuticals GAAP EPS of -$0.91, revenue of $0.47M
SA Breaking News
02/17 17:11
InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update
Globe Newswire
02/17 17:00
INmune Bio to fund Alzheimer’s trial with over $6M R&D rebates
SA Breaking News
02/08 09:25
Xylem, Catalyst Pharmaceuticals, Jaguar Health among premarket losers' pack
SA Breaking News
01/23 08:34
SLRX, CNET and WISA among mid-day movers
SA Breaking News
01/20 13:18
Sotera, Prenetics top healthcare gainers; BioAtla, G Medical lead losers' pack
SA Breaking News
01/10 10:02
InMed Provides Business Update and Milestones for 2023
Globe Newswire
01/10 07:30
NMTR and SLRX among healthcare movers
SA Breaking News
01/05 10:30
CrowdStrike Holdings, Coinbase Global, GDS Holdings among premarket losers' pack
SA Breaking News
01/05 08:52
Top Premarket Decliners
MT Newswires
01/05 07:46
JD, BZUN and FUTU are among pre market gainers
SA Breaking News
01/04 08:59
Thinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun?
PR Newswire
01/04 08:36
Top Premarket Gainers
MT Newswires
01/04 07:49
FUTU, TIGR and PALI among mid-day gainers and losers
SA Breaking News
12/30 12:43
InMed Pharmaceuticals Appoints Jonathan Tegge as Interim Finance Chief
MT Newswires
12/13 03:36
InMed Pharmaceuticals appoints interim CFO
SA Breaking News
12/13 02:22
CDLX, RXT and BIVI among mid-day movers
SA Breaking News
12/08 13:11
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
Globe Newswire
11/21 17:00
Sector Update: Health Care Stocks Finishing Near Friday Session Highs
MT Newswires
11/18 15:58
Sector Update: Healthcare
MT Newswires
11/18 15:46
Top Midday Decliners
MT Newswires
11/18 14:25
InMed Pharmaceuticals Announces $6 Million Share Placement Deal With Two Investors; Stock Slips
MT Newswires
11/18 09:59
InMed Pharmaceuticals dips after pricing ~$6M private offering
SA Breaking News
11/18 08:31
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
Globe Newswire
11/18 08:00
InMed Provides Update on Management Changes
Globe Newswire
11/17 07:30
Top Midday Gainers
MT Newswires
11/16 14:10
Thinking about buying stock in Fast Radius, Camber Energy, InMed Pharmaceuticals, Taiwan Semiconductor, or Exela Technologies?
PR Newswire
11/16 11:16
InMed, AirSculpt top healthcare gainers; BrainsWay, Brookdale among losers
SA Breaking News
11/16 10:01
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
Globe Newswire
11/16 07:00
InMed Pharmaceuticals GAAP EPS of -$4.06, revenue of $0.32M
SA Breaking News
11/14 01:12
Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022
Globe Newswire
11/10 07:30
InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week
Globe Newswire
10/26 07:30
NCLH, BHIL and CMRA among mid-day movers
SA Breaking News
09/30 12:12
Ainos, InMed top healthcare gainers; Intercept, Axcella lead losers' pack
SA Breaking News
09/30 10:04
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
Globe Newswire
09/23 12:29
Thinking about buying stock in Aditxt, Scisparc, Akerna, InMed Pharmaceuticals, or Eos Energy?
PR Newswire
09/14 08:30
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
Globe Newswire
09/13 17:12
Sector Update: Health Care Stocks Consolidating Earlier Rise Near Monday Close
MT Newswires
09/12 16:02
Top Midday Gainers
MT Newswires
09/12 13:46
Top Premarket Gainers
MT Newswires
09/09 07:52
InMed Pharmaceuticals Provides Update on its Core Research and Development Programs and BayMedica Business
Globe Newswire
09/08 14:08
Wall Street Futures Tread Water as Jackson Hole Looms
MT Newswires
08/24 09:27
Top Premarket Decliners
MT Newswires
08/24 08:04
InMed Pharmaceuticals to Implement 1-for-25 Share Consolidation; Stock Down After Hours
MT Newswires
08/23 17:13
InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria
Globe Newswire
08/23 17:00
InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
Globe Newswire
07/25 07:30
InMed Pharmaceuticals Promotes Michael Woudenberg to Chief Operating Officer
MT Newswires
07/18 08:28
InMed names new COO
SA Breaking News
07/18 07:35
InMed Announces Appointment of Chief Operating Officer
Globe Newswire
07/18 07:30
InMed Pharmaceuticals Receives Nasdaq Notice for Non-Compliance With Continued-Listing Rule
MT Newswires
07/13 03:19
InMed Pharmaceuticals gets non-compliance notice on Nasdaq minimum bid price requirement
SA Breaking News
07/13 03:08
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
Globe Newswire
07/12 23:33
InMed says peer-reviewed study highlights potential role of rare cannabinoids THCV, CBC on skin conditions
SA Breaking News
06/14 10:05
InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions
Globe Newswire
06/14 07:30
InMed Pharmaceuticals Unit Launches New Cannabinoid Product
MT Newswires
06/09 08:35
InMed Pharmaceuticals Closes $5 Million Registered Direct Offering, Private Placement
MT Newswires
06/07 03:23
InMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
Globe Newswire
06/02 08:00
--Roth Capital Downgrades InMed Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $0.80 From $6
MT Newswires
05/16 08:31
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
Globe Newswire
05/13 07:30
InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV
Globe Newswire
05/05 07:30
InMed Pharmaceuticals (INM): Notable Launches of High-Value Rare Cannabinoids
Accesswire
05/03 12:00
InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert
Globe Newswire
04/28 07:30
Top Premarket Decliners
MT Newswires
04/26 07:55
InMed launches sale of cannabidivarin in U.S.
SA Breaking News
04/21 12:13
InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
Globe Newswire
04/21 07:30
InMed to Participate in Upcoming Investor Conferences in April and May 2022
Globe Newswire
04/19 07:30
InMed Pharmaceuticals Sets Up $4.25 Million At-The-Market Equity Offering Program
MT Newswires
04/08 10:45
Sector Update: Health Care Stocks Easing as Other Sectors Gain
MT Newswires
03/17 15:55
Sector Update: Health Care Leading Most Other Sectors This Afternoon
MT Newswires
03/17 14:07
InMed CFO Bruce Colwill to Retire
MT Newswires
03/17 07:44
InMed Announces Management Changes
Globe Newswire
03/17 07:30
InMed to Present at the 34th Annual Roth Conference
Globe Newswire
03/08 07:30
InMed Pharmaceuticals (INM): Generating Commercial Sales of CBC and CBT
Accesswire
02/16 07:30
InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica
Globe Newswire
02/15 07:30
InMed Pharmaceuticals GAAP EPS of -$0.31, revenue of $0.27M
SA Breaking News
02/15 03:06
InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update
Globe Newswire
02/14 19:34
InMed launches B2B sales of rare cannabinoid cannabicitran
SA Breaking News
01/19 12:11
InMed Pharmaceuticals Starts Selling Rare Cannabinoid Cannabicitran
MT Newswires
01/19 07:59
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
Globe Newswire
01/19 07:30
Registration Now Open For Tribe Public’s Webinar Event "Addressing The Increasing Demand For Rare Cannabinoids" Featuring InMed’s Management Team On January 6, 2022
Globe Newswire
12/30 07:30
InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of CBN as a Potential Treatment for Glaucoma
Globe Newswire
12/20 07:30
InMed Announces Results of 2021 Annual General Meeting
Globe Newswire
12/17 19:57
Thinking about buying stock in Adagio Therapeutics, 180 Life Sciences, InMed Pharmaceuticals, Beyondspring, or Inovio Pharmaceuticals?
PR Newswire
11/29 08:30
--HC Wainwright Starts InMed Pharmaceuticals at Buy With $6 Price Target
MT Newswires
11/29 07:12
InMed Pharmaceuticals to Participate in Cowen’s 4th Annual Cannabis Conference
Globe Newswire
11/23 07:30
Top Premarket Decliners
MT Newswires
11/18 08:09
InMed Pharma soars after releasing extracts from research report
SA Breaking News
11/17 11:26
Thinking about buying stock in Camber Energy, New Oriental Education, InMed Pharmaceuticals, Rockwell Medical, or IONQ Inc?
PR Newswire
11/17 10:50
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
Globe Newswire
11/10 07:30
InMed Pharma Files Patent Application For Rare Cannabinoid to Treat Neurodegenerative Diseases
MT Newswires
11/03 11:17
Biotricity, Chemomab Therapeutics leads healthcare gainers; Capital Senior Living, Adial Pharmaceuticals among major losers
SA Breaking News
10/21 11:03
Thinking about buying stock in Nextplay Technologies, Sio Gene Therapies, Kadmon, Senseonics, or InMed Pharmaceuticals?
PR Newswire
10/21 08:35
SESN, KDMN and RMED among pre market gainers
SA Breaking News
10/21 08:32
IONS, BTCS and NXTD among mid-day movers
SA Breaking News
10/18 12:43
Thinking about buying stock in Ion Geophysical, Valneva SE, Adamis Pharmaceuticals, Oyster Point Pharma, or InMed Pharmaceuticals?
PR Newswire
10/18 08:30
FCEL, INFI and SIOX among pre market gainers
SA Breaking News
10/18 08:15
InMed Pharmaceuticals Completes BayMedica Acquisition
MT Newswires
10/14 04:31
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
Globe Newswire
10/13 16:30
InMed Begins Phase 2 Study of Cannabinol Cream for Treatment of Epidermolysis Bullosa
MT Newswires
09/30 07:56
InMed Pharmaceuticals Announces Commencement of Phase 2 Clinical Trial Investigating Cannabinol (CBN), a Rare Cannabinoid, in the Treatment of Epidermolysis Bullosa
Globe Newswire
09/30 07:30
InMed Narrows Loss for Fiscal 2021, while Expenses Rise
MT Newswires
09/24 08:14
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update
Globe Newswire
09/24 07:30
InMed Pharmaceuticals (INM): Acquiring BayMedica
Accesswire
09/20 07:50
InMed Pharmaceuticals to Report Full Year Fiscal 2021 Financial Results and Business Update on September 24, 2021
Globe Newswire
09/17 13:14
InMed Pharmaceuticals and BayMedica Participating in Tribe Public’s Webinar "Accelerating The Commercialization of Rare Cannabinoids"
Globe Newswire
09/17 07:30
UEC, HEPA and YPF among pre market gainers
SA Breaking News
09/13 08:32
InMed Pharmaceuticals to Acquire BayMedica
MT Newswires
09/13 08:26
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
PR Newswire
09/13 07:32
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids
Globe Newswire
09/13 07:30
InMed Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Globe Newswire
09/09 19:18
InMed Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com September 8th
PR Newswire
09/07 16:04
Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th
PR Newswire
09/02 08:35
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement Priced At-the-Market under Nasdaq Rules
Globe Newswire
07/02 16:15
Technology and Healthcare names dominate premarket gainers
SA Breaking News
06/29 08:25
InMed Pharma signs LOI to acquire rare cannabinoids manufacturer BayMedica
SA Breaking News
06/29 07:42
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
Globe Newswire
06/29 07:00
InMed Pharmaceuticals Announces $12 Million Private Placement Priced At-the-Market under Nasdaq Rules
Globe Newswire
06/29 07:00
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Globe Newswire
06/28 08:35
InMed Pharmaceuticals to Webcast Live at Life Sciences Investor Forum June 24th
Globe Newswire
06/22 12:29
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021
Globe Newswire
06/21 08:35
InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn™ in Advance of Commercial Scale Production
Globe Newswire
06/17 07:30
InMed Pharmaceuticals to Present at the 2021 BIO Digital Conference
Globe Newswire
06/09 11:30
InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results
Globe Newswire
05/13 07:30
InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results
Globe Newswire
05/06 07:30
InMed to Present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11th, 2021
Globe Newswire
05/04 07:30
InMed Pharma files applications to evaluate INM-755 for epidermolysis bullosa
SA Breaking News
04/28 08:45
InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
Globe Newswire
04/28 07:30
InMed Pharmaceuticals Announces Voluntary Delisting from TSX
Globe Newswire
04/27 07:30
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™
Globe Newswire
04/26 07:30
InMed to Present at Virtual Conferences in March 2021
Globe Newswire
03/03 18:00
InMed Announces Closing of US$4.5 Million Private Placement
PR Newswire
02/16 07:30
InMed Pharmaceuticals reports Q4 results
SA Breaking News
02/11 07:42
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
PR Newswire
02/11 07:30
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results
PR Newswire
02/05 21:00
InMed to raise $4.5M in private placement
SA Breaking News
02/05 09:44
InMed Announces US$4.5 Million Private Placement
PR Newswire
02/05 09:34
Tyme Technologies, GW Pharmaceuticals leads healthcare gainers; Vaxart, Moleculin Biotech among major losers
SA Breaking News
02/03 11:02
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe
PR Newswire
01/19 14:00
InMed's INM-755 CBN cream did not introduce any delay in normal wound healing
SA Breaking News
01/08 08:27
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
PR Newswire
01/08 07:30
InMed to Participate at Virtual Conferences in January 2021
PR Newswire
01/05 16:52
SUPN, CLNE, MGNI and LIZI among premarket gainers
SA Breaking News
12/23 08:43
InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
PR Newswire
12/03 07:30
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
PR Newswire
11/25 07:30
InMed Announces Election of Directors
PR Newswire
11/24 20:00
InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics
PR Newswire
11/18 07:30
InMed Pharmaceuticals Announces the Closing of US$8 Million Public Offering
PR Newswire
11/16 11:42
InMed Pharmaceuticals Reports First Quarter Fiscal 2021 IFRS Financial Results
PR Newswire
11/13 07:30
InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM"
PR Newswire
11/12 09:10
InMed Reschedules Reporting of First Quarter Financial Results and Business Update to November 13, 2020
PR Newswire
11/05 18:21
InMed Pharmaceuticals to Report First Quarter Fiscal 2021 Financial Results and Business Update on November 6, 2020
PR Newswire
11/04 07:30
InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
PR Newswire
09/24 07:30
InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing
PR Newswire
09/22 07:30
InMed Pharmaceuticals reports FY results
SA Breaking News
09/08 07:32
InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update
PR Newswire
09/08 07:30
InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020
PR Newswire
09/02 07:30
Dosing underway in InMed Pharma's early-stage INM-755 trial
SA Breaking News
07/07 09:32
InMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755
PR Newswire
07/07 07:30
InMed Announces Completion of Share Consolidation
PR Newswire
06/30 18:18
InMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System
PR Newswire
06/24 07:30
InMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation
PR Newswire
06/19 18:20
InMed Releases CBN Preclinical Results in Glaucoma
PR Newswire
05/27 07:30
InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
PR Newswire
05/19 07:30
InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
PR Newswire
05/14 07:30
InMed Files PCT Patent Application for Neuroprotection in Glaucoma
PR Newswire
05/12 07:30
InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
PR Newswire
05/08 07:30
InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference
PR Newswire
05/07 07:30
InMed and Almac Group Developing Improved Cannabinoid Production Methods
PR Newswire
05/05 07:30
InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
PR Newswire
04/30 07:30
InMed completes initial early-stage INM-755 CBN cream trial
SA Breaking News
04/01 08:14
InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
PR Newswire
04/01 07:30
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
PR Newswire
03/24 07:30
InMed provides corporate update
SA Breaking News
03/20 07:59
InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
PR Newswire
03/20 07:30
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
PR Newswire
03/10 13:24
Edison issues update on InMed Pharmaceuticals (IN)
Accesswire
02/20 09:15
InMed Pharmaceuticals reports Q2 results
SA Breaking News
02/14 07:34
InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
PR Newswire
02/14 07:30
InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020
PR Newswire
02/07 07:30
Baird downgrades Amgen on soft guidance in premarket analyst action
SA Breaking News
01/31 08:33
InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
PR Newswire
01/21 07:30
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
PR Newswire
01/20 07:30
InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress
PR Newswire
01/16 07:30
InMed Announces Election of Directors
PR Newswire
01/10 17:56
InMed Pharmaceuticals to Present at the Biotech Showcase Conference
PR Newswire
01/08 07:30
Global OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing
PR Newswire
12/09 08:35
InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
PR Newswire
12/09 07:30
Live Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th
PR Newswire
12/02 08:35
Live Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th
PR Newswire
11/25 08:35
InMed Pharmaceuticals to Present at the Cowen Conference
PR Newswire
11/11 08:30
InMed Pharmaceuticals reports Q1 results
SA Breaking News
11/08 07:37
InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
PR Newswire
11/08 07:30
InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
PR Newswire
11/05 07:30
InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019
PR Newswire
11/04 07:30
InMed Pharmaceuticals to Present at the BIO Investor Forum
PR Newswire
10/18 12:25
InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference
PR Newswire
09/23 11:00
InMed Pharmaceuticals reports Q4 results
SA Breaking News
09/19 07:39
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
PR Newswire
09/19 07:30
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
PR Newswire
09/12 11:00
Key events next week - healthcare
SA Breaking News
09/06 08:34
InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
PR Newswire
09/03 07:25
InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
PR Newswire
08/29 07:25
New finance chief at InMed Pharma
SA Breaking News
08/02 08:56
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
PR Newswire
08/02 07:25
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
PR Newswire
07/02 07:25
OTC Markets Group Launches OTCQX Cannabis Index
PR Newswire
06/04 07:00
InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
PR Newswire
05/15 07:25
InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
PR Newswire
05/08 07:25
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
PR Newswire
03/18 07:25
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
PR Newswire
03/13 16:01
InMed Pharma pivots to single-agent cannabinoid for rare skin disorder; shares up 2%
SA Breaking News
03/13 11:42
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program
PR Newswire
03/13 07:25
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019
PR Newswire
03/12 07:25
InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board
PR Newswire
03/06 07:25
InMed Pharmaceuticals reports Q2 results
SA Breaking News
02/12 07:27
InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
PR Newswire
02/12 07:25
InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
PR Newswire
02/05 07:25
InMed Pharmaceuticals' Chief Scientific Officer retires
SA Breaking News
01/11 07:46
InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
PR Newswire
01/11 07:25
InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
PR Newswire
01/03 10:25
InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program
PR Newswire
12/04 07:25
InMed Pharmaceuticals reports Q1 results
SA Breaking News
11/12 07:39
InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
PR Newswire
11/12 07:25
InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018
PR Newswire
11/05 07:25
InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls
PR Newswire
11/05 07:20
InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018
PR Newswire
10/10 07:25
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up
PR Newswire
10/03 07:25
Canadian Cannabis Upcoming Legalization Expected to Transform the Legal Marijuana Industry Across North America
PR Newswire
09/26 08:50
InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids
PR Newswire
09/25 07:25
Growing Need for Medical and Recreational Cannabis Looks to Continue Globally
PR Newswire
09/17 09:00
InMed Pharmaceuticals reports Q4 results
SA Breaking News
09/13 07:35
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update
PR Newswire
09/13 07:25
InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work
PR Newswire
09/11 07:25
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
PR Newswire
09/10 07:25
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018
PR Newswire
09/07 07:25
The Legal Cannabis Market is set to Expand as CBD Demand Grows Globally
PR Newswire
09/05 09:00